Population Characteristics
HIV, human immunodeficiency virus
CORONAVIRUS DISEASE 2019
Of the 1070 participants in CSSC-004 with complete symptom data through day 14 who were randomized and transfused with either CCP (n = 538) or control plasma (n = 532), 291 (54.1%) in the CCP and 318 (59.8%) in the control group were female (Characteristics of Trial ParticipantsAbbreviations: BMI, body mass index; CCP, COVID-19 convalescent plasma; COVID-19, coronavirus disease 2019; HIV, human immunodeficiency virus.BMI calculated as weight in kilograms divided by height in meters squared.